HIV-associated sensory neuropathies

Peripheral neuropathy has emerged as the most common neurological complication of HIV infection [1– 4]. There are several discrete types of HIV-associated neuropathy, which can be classified according to the timing of their appearance during HIV infection, their etiology and whether they are primarily axonal or demyelinating (Table 1). Some represent a consequence of HIV infection producing neuropathological damage [e.g., distal symmetrical polyneuropathy (DSP)], while others are related to opportunistic pathogens [e.g., cytomegalovirus (CMV) polyradiculitis]. An increasingly common group is that which occurs as a result of treatment toxicity [e.g., toxic neuropathy from antiretroviral drugs (TNA) and lactic acidosis syndrome].

[1]  D. Katzenstein,et al.  Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels , 2002, AIDS.

[2]  K. Anderson,et al.  Toxicity of Antiviral Nucleoside Analogs and the Human Mitochondrial DNA Polymerase* , 2001, The Journal of Biological Chemistry.

[3]  William Lewis,et al.  Combined Antiretroviral Therapy Causes Cardiomyopathy and Elevates Plasma Lactate in Transgenic AIDS Mice , 2001, Laboratory Investigation.

[4]  M. Dalakas,et al.  Mitochondrial Alterations with Mitochondrial DNA Depletion in the Nerves of AIDS Patients with Peripheral Neuropathy Induced by 2′3′-Dideoxycytidine (ddC) , 2001, Laboratory Investigation.

[5]  D. Katzenstein,et al.  Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy , 2001, Neurology.

[6]  C. Pardo,et al.  Human immunodeficiency virus and the peripheral nervous system workshop. , 2001, Archives of neurology.

[7]  R J Miller,et al.  Chemokines and Glycoprotein120 Produce Pain Hypersensitivity by Directly Exciting Primary Nociceptive Neurons , 2001, The Journal of Neuroscience.

[8]  Kenneth A. Johnson,et al.  Insights into the Molecular Mechanism of Mitochondrial Toxicity by AIDS Drugs* , 2001, The Journal of Biological Chemistry.

[9]  J. Sagen,et al.  Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis , 2001, Journal of Neuroimmunology.

[10]  James N. Campbell,et al.  Early Onset of Spontaneous Activity in Uninjured C-Fiber Nociceptors after Injury to Neighboring Nerve Fibers , 2001, The Journal of Neuroscience.

[11]  L. Sorkin,et al.  Upregulation of Dorsal Root Ganglion α2δ Calcium Channel Subunit and Its Correlation with Allodynia in Spinal Nerve-Injured Rats , 2001, The Journal of Neuroscience.

[12]  A. Verma Epidemiology and clinical features of HIV‐1 associated neuropathies , 2001, Journal of the peripheral nervous system : JPNS.

[13]  M. Dalakas Peripheral neuropathy and antiretroviral drugs , 2001, Journal of the peripheral nervous system : JPNS.

[14]  J W Griffin,et al.  HIV neuropathy: Insights in the pathology of HIV peripheral nerve disease , 2001, Journal of the peripheral nervous system : JPNS.

[15]  J. Becker,et al.  HIV-associated neurologic disease incidence changes: , 2001, Neurology.

[16]  F. Maggiolo,et al.  Gabapentin in painful HIV‐related neuropathy: a report of 19 patients, preliminary observations , 2001, European journal of neurology.

[17]  G. Moyle Toxicity of Antiretroviral Nucleoside and Nucleotide Analogues , 2000, Drug safety.

[18]  D. Simpson,et al.  Peripheral neuropathy associated with acquired immunodeficiency syndrome (AIDS)–related Burkitt's lymphoma , 2000, Muscle & nerve.

[19]  H. Manji Neuropathy in HIV infection , 2000, Current opinion in neurology.

[20]  A. Telenti,et al.  Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection , 2000, AIDS.

[21]  O. Nascimento,et al.  Distal sensory polyneuropathy in a cohort of HIV-infected children over five years of age. , 2000, Pediatrics.

[22]  L. Wilkins A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection , 2000, Neurology.

[23]  T. Hassanein,et al.  Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  A. Sönnerborg,et al.  Antiretroviral therapy may improve sensory function in HIV-infected patients , 2000, Neurology.

[25]  D. Simpson,et al.  A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy , 2000, Neurology.

[26]  T. Kakuda,et al.  Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. , 2000, Clinical therapeutics.

[27]  S. Maier,et al.  Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120 , 2000, Brain Research.

[28]  R. Meyer,et al.  Mechanical hyperalgesia after an L5 spinal nerve lesion in the rat is not dependent on input from injured nerve fibers , 2000, Pain.

[29]  D. Katzenstein,et al.  A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection , 2000, Neurology.

[30]  V. Darley-Usmar,et al.  Differential Effects of Antiretroviral Nucleoside Analogs on Mitochondrial Function in HepG2 Cells , 2000, Antimicrobial Agents and Chemotherapy.

[31]  J. McArthur,et al.  Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea , 2000, AIDS.

[32]  B. Sumegi,et al.  Molecular mechanism of the short-term cardiotoxicity caused by 2',3'-dideoxycytidine (ddC): modulation of reactive oxygen species levels and ADP-ribosylation reactions. , 1999, Biochemical pharmacology.

[33]  K. Conant,et al.  Cerebrospinal fluid levels of MMP‐2, 7, and 9 are elevated in association with human immunodeficiency virus dementia , 1999, Annals of neurology.

[34]  A. Cross,et al.  Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3. , 1999, Journal of acquired immune deficiency syndromes.

[35]  D. Simpson,et al.  Treatment of painful distal sensory polyneuropathy in HIV-infected patients with a topical agent: results of an open-label trial of 5% lidocaine gel. , 1999, AIDS.

[36]  J. Arezzo,et al.  Prevalence of peripheral neuropathy in injection drug users , 1999, Neurology.

[37]  S. Waxman The molecular pathophysiology of pain: abnormal expression of sodium channel genes and its contributions to hyperexcitability of primary sensory neurons , 1999, Pain.

[38]  A. Cross,et al.  Relation of peripheral neuropathy to HIV treatment in four randomized clinical trials including didanosine. , 1999, Clinical therapeutics.

[39]  J. Becker,et al.  Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy , 1999, Neurology.

[40]  T. Doubell,et al.  Peripheral Inflammation Facilitates Aβ Fiber-Mediated Synaptic Input to the Substantia Gelatinosa of the Adult Rat Spinal Cord , 1999, The Journal of Neuroscience.

[41]  C. Kemper,et al.  Mexiletine for HIV-infected patients with painful peripheral neuropathy: a double-blind, placebo-controlled, crossover treatment trial. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[42]  C. Yiannoutsos,et al.  A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection , 1998, Neurology.

[43]  K. Chaloner,et al.  Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. , 1998, JAMA.

[44]  P. Shapshak,et al.  Morphometric analysis of the peripheral neuropathy of AIDS , 1998, Muscle & nerve.

[45]  G. Nuovo,et al.  Human immunodeficiency virus infection of dorsal root ganglion neurons detected by polymerase chain reaction in situ hybridization , 1997, Annals of neurology.

[46]  K. Kieburtz,et al.  HIV related vasculitic mononeuropathy multiplex: A role for IVIg? , 1997, Journal of neurology, neurosurgery, and psychiatry.

[47]  G. Barlovatz-Meimon,et al.  Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells , 1997, Journal of the Neurological Sciences.

[48]  C. Woolf,et al.  Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor α , 1997, British journal of pharmacology.

[49]  D. Valenti,et al.  3'-Azido-3'-deoxythmidine uptake into isolated rat liver mitochondria and impairment of ADP/ATP translocator. , 1997, Biochemical pharmacology.

[50]  J. Sommadossi,et al.  Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells. , 1997, The Journal of pharmacology and experimental therapeutics.

[51]  J. McArthur,et al.  Intraepidermal nerve fiber density in patients with painful sensory neuropathy , 1997, Neurology.

[52]  A. Verma,et al.  Painful vasculitic neuropathy in HIV-1 infection , 1996, Neurology.

[53]  R. Myers,et al.  Endoneurial injection of TNF-α produces neuropathic pain behaviors , 1996 .

[54]  R. Coggeshall,et al.  Collateral Sprouting of Uninjured Primary Afferent A-Fibers into the Superficial Dorsal Horn of the Adult Rat Spinal Cord after Topical Capsaicin Treatment to the Sciatic Nerve , 1996, The Journal of Neuroscience.

[55]  S. Ueno,et al.  Prosaposin Facilitates Sciatic Nerve Regeneration In Vivo , 1996, Journal of neurochemistry.

[56]  G. D. Dal Pan,et al.  Low-dose zalcitabine-related toxic neuropathy , 1996, Neurology.

[57]  P. Shapshak,et al.  Increased NADPH-diaphorase reactivity and cytokine expression in dorsal root ganglia in acquired immunodeficiency syndrome , 1996, Journal of the Neurological Sciences.

[58]  J. Arezzo,et al.  Didanosine (ddl) and stavudine (d4T): absence of peripheral neurotoxicity in rabbits. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[59]  C. Fichtenbaum,et al.  Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[60]  S. Wesselingh,et al.  Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[61]  S. Keilbaugh,et al.  Cellular targets of 3'-azido-3'-deoxythymidine: an early (non-delayed) effect on oxidative phosphorylation. , 1995, Biochemical pharmacology.

[62]  M. Tagliati,et al.  Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[63]  M. Dalakas,et al.  Mitochondrial toxicity of antiviral drugs , 1995, Nature Medicine.

[64]  C. Chalk,et al.  Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease , 1994, Journal of virology.

[65]  S. Keilbaugh,et al.  Mechanisms of toxicity of 3'-azido-3'-deoxythymidine. Its interaction with adenylate kinase. , 1994, Biochemical pharmacology.

[66]  J. Becker,et al.  Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. , 1994, Neurology.

[67]  P. Shapshak,et al.  Expression of HIV‐1 and interleukin‐6 in lumbosacral dorsal root ganglia of patients with AIDS , 1994, Neurology.

[68]  Y. So,et al.  Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: Experience in 23 patients , 1994, Annals of neurology.

[69]  J. Modica-Napolitano AZT causes tissue-specific inhibition of mitochondrial bioenergetic function. , 1993, Biochemical and biophysical research communications.

[70]  C. Lamotte,et al.  Deafferentation‐induced terminal field expansion of myelinated saphenous afferents in the adult rat dorsal horn and the nucleus gracilis following pronase injection of the sciatic nerve , 1993, The Journal of comparative neurology.

[71]  J C Arezzo,et al.  2',3'‐Dideoxycytidine (ddC) toxic neuropathy , 1993, Neurology.

[72]  G. Gronseth,et al.  Peripheral nervous system involvement in a large cohort of human immunodeficiency virus-infected individuals. , 1993, Archives of neurology.

[73]  L. Thal,et al.  Sensory testing in human immunodeficiency virus type 1-infected men. HIV Neurobehavioral Research Center Group. , 1992, Archives of neurology.

[74]  J. Hauw,et al.  Lymphoma-induced polyradiculopathy in AIDS: Two cases , 1992, Journal of Neurology.

[75]  C. H. Chen,et al.  Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. , 1991, Molecular pharmacology.

[76]  C. Lacroix,et al.  Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: A clinical and pathological study , 1991, Annals of neurology.

[77]  D. Holtzman,et al.  Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey. , 1988, Archives of neurology.

[78]  D. Lanska,et al.  Syphilitic polyradiculopathy in an HIV‐positive man , 1988, Neurology.

[79]  D. Cornblath,et al.  Predominantly sensory neuropathy in patients with AIDS and AIDS‐related complex , 1988, Neurology.

[80]  R. Schooley,et al.  Peripheral neuropathy in the acquired immunodeficiency syndrome , 1988, Annals of neurology.

[81]  D. Price,et al.  Gracile tract degeneration in patients with sensory neuropathy and AIDS , 1988, Neurology.

[82]  J. Griffin,et al.  Inflammatory demyelinating peripheral neuropathies associated with human T‐cell lymphotropic virus type III infection , 1987, Annals of neurology.

[83]  C. Crumpacker,et al.  Progressive polyradiculopathy in acquired immune deficiency syndrome , 1986, Neurology.

[84]  G. Zanette,et al.  Role of HIV in the pathogenesis of distal symmetrical peripheral neuropathy , 2004, Acta Neuropathologica.

[85]  E. Huang,et al.  Neurotrophins: roles in neuronal development and function. , 2001, Annual review of neuroscience.

[86]  S. Shott,et al.  Topical capsaicin in the management of HIV-associated peripheral neuropathy. , 2000, Journal of pain and symptom management.

[87]  Joakim Bjorkdahl Prevalence of peripheral neuropathy in injection drug users. , 2000 .

[88]  S. Kaul,et al.  Toxicokinetics of 2',3'-didehydro-3'-deoxythymidine, stavudine (D4T). , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[89]  M. Tagliati,et al.  Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings. , 1999, Archives of neurology.

[90]  D. Spelman,et al.  An analysis of factors associated with HIV-related peripheral neuropathy , 1997 .

[91]  R. Myers,et al.  Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. , 1996, Neuroreport.

[92]  L. Caniatti,et al.  Cryoglobulinemic neuropathy related to hepatitis C virus infection. Clinical, laboratory and neurophysiological study. , 1996, Journal of the peripheral nervous system : JPNS.

[93]  C. Lamotte,et al.  Deafferentation-induced expression of GAP-43, NCAM, and NILE in the adult rat dorsal horn following pronase injection of the sciatic nerve. , 1995, Somatosensory & motor research.

[94]  S. Steinberg,et al.  2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial. , 1993, The Journal of infectious diseases.

[95]  T. Anderson,et al.  Ultrastructure of peripheral neuropathy induced in rabbits by 2',3'-dideoxycytidine. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[96]  H. Schaumburg,et al.  Peripheral neuropathy induced by 2',3'-dideoxycytidine. A rabbit model of 2',3'-dideoxycytidine neurotoxicity. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[97]  J. Gastaut,et al.  [Peripheral neuropathies in human immunodeficiency virus infection. A prospective study of 56 patients]. , 1989, Revue neurologique.